iSERA Lifesciences to Hold Board Meeting to Approve Un-Audited Financial Results for June 30, 2026
iSERA Lifesciences Ltd, previously known as Covidh Technologies Limited, has scheduled a meeting of its Board of Directors to consider and approve the Un-Audited Financial Results for the quarter and year ended on June 30, 2026.The Board meeting is set for Friday, August 7, 2026. The company will review and take record of the financial results pertaining to the specified period.
In addition to the management review of the financials, iSERA Lifesciences announced operational status regarding its equity shares trading window. Following relevant provisions, the trading window for all designated persons remains closed. This closure commenced on Wednesday, July 1, 2026, and will continue until 48 hours after the results for the quarter and year ended on June 30, 2026, are made public.
Stock Price Movement
At 12:15, iSERA Lifesciences Ltd. shares hold steady at ₹143.90 in the market, showing no change for the day. The stock remains completely locked, as its intraday high and low have both registered at this price point of ₹143.90.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.